Peterson Amy C. Insider Trades

Insider Trading History

Track insider trading activity for Peterson Amy C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $6.16M 120,000 shares
Last Trade
May 16, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.82M 40,000 shares
$45.40
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $23.9M 465,393 shares
Last Trade
May 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.31M 72,776 shares
$45.47
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $27.6M 538,169 shares
Last Trade
May 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.82M 40,000 shares
$45.40
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $25.6M 498,169 shares
Last Trade
May 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$371k 8,303 shares
$44.65
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $26M 506,472 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.88M 159,383 shares
$36.92
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $17.8M 347,089 shares
Last Trade
Feb 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.96M 52,192 shares
$37.53
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $15.1M 294,897 shares
Last Trade
Nov 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$954k 27,224 shares
$35.05
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $16.5M 322,121 shares
Last Trade
Feb 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.77M 82,121 shares
$21.53
$51.34
Exelixis
Exelixis EXEL
EVP Prod Dev & Med Aff & CMO
Holding Value $12.3M 240,000 shares
Last Trade
Aug 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.48M 160,000 shares
$21.75
$51.34
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $184k 58,433 shares
Last Trade
Mar 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.43k 4,257 shares
$1.98
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $197k 62,690 shares
Last Trade
Jul 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.6k 7,463 shares
$1.42
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $221k 70,153 shares
Last Trade
Jul 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30k 20,000 shares
$1.50
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $630k 200,000 shares
Last Trade
Feb 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$991k 240,000 shares
$4.13
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $158k 50,000 shares
Last Trade
Oct 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$481k 90,000 shares
$5.34
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $20.2k 6,421 shares
Last Trade
May 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.8k 3,320 shares
$7.16
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $788k 250,000 shares
Last Trade
Feb 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.96M 250,000 shares
$7.85
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $9.77k 3,101 shares
Last Trade
Nov 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.3k 3,101 shares
$7.52
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $78.8k 25,000 shares
Last Trade
Feb 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 25,000 shares
$7.13
$3.15
CytomX Therapeutics
CytomX Therapeutics CTMX
Evp, Chief Development Officer
Holding Value $1.26M 400,000 shares
Last Trade
Oct 15, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.86M 400,000 shares
$7.16
$3.15
BeiGene
BeiGene BGNE
Cmo, Immuno-oncology
Holding Value $1.57M 8,510 shares
Last Trade
Dec 18, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.36M 10,141 shares
$133.75
$184.71

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up